Browse treatments

…group showed significantly lower mean cholesterol and TG level. Triple therapy group showed a lower discharge NIHSS (2.7 ± 2.2 vs. 5.5 ± 6.9, …

… reduction without drug class restriction. The effectiveness of triple therapy (early aggressive strategy) comprising a proprotein convertase …

…ers of disease activity and can normalise ALP in some patients. Triple therapy can also have a positive impact on pruritus management in patie…

…ion. This meta-analysis aims to identify the non-inferiority of Vonoprazan-based triple therapy to standard proton pump inhibitor (PPI)-based therapy in the tr…

…COPD), increasing hospitalisation and exacerbation rates. While inhaled therapy is a cornerstone of COPD management, pressurised metered-dose i…

…ients with elevations in peripheral eosinophils uncontrolled on triple therapy.10 Although approaches based on systemic metrics can identify e…

…or both ITT (P-score=0.9436) and PP (P-score=0.9545).Conclusion Dual therapy represents a promising first-line option, demonstrating compara…

…flammation (screening blood eosinophil counts ≥300 cells/µL) on triple therapy. Patients received add-on dupilumab or placebo for 52 weeks. En…

…e 2 inflammation (screening blood eosinophils ≥300 cells/µL) on triple therapy. Patients received add-on subcutaneous dupilumab 300 mg or matc…

…e 2 inflammation (screening blood eosinophils ≥300 cells/µL) on triple therapy. Patients received dupilumab 300 mg or placebo q2w for 52 weeks…

…d to AZA) and 59.7 months (22.2–119.1) in patients treated with triple therapy (n = 18). Two cases of viremia, two abscesses, two chest infect…